RhDAntigens

RhD antigens are a group of cell surface proteins that are part of the Rh blood group system. The most important and immunogenic of these is the D antigen, which determines whether a person is Rh-positive or Rh-negative. The presence of the D antigen makes an individual Rh-positive, while its absence makes them Rh-negative. This classification is crucial in blood transfusions and during pregnancy.

The Rh blood group system is inherited, with genes on chromosome 1 located on the RHD and RHCE genes. The RHD gene is responsible for the D antigen. Individuals inherit a combination of alleles that dictate their RhD status. Approximately 85% of the Caucasian population is Rh-positive, but this prevalence varies among different ethnic groups.

RhD incompatibility between a pregnant mother and her fetus can lead to hemolytic disease of the newborn (HDN). If an Rh-negative mother carries an Rh-positive fetus, her immune system may recognize the fetal D antigen as foreign and produce antibodies against it. This can occur during pregnancy or delivery. If the mother produces anti-D antibodies, these can cross the placenta and attack the red blood cells of subsequent Rh-positive pregnancies, causing anemia, jaundice, and potentially severe complications in the fetus or newborn.

To prevent RhD alloimmunization, Rh-negative pregnant women are typically given Rh immunoglobulin (RhIG), commonly known as RhoGAM. This injection contains anti-D antibodies that bind to any fetal Rh-positive red blood cells that may enter the mother's bloodstream, preventing her from developing her own immune response. RhD status is also a critical consideration when transfusing blood; Rh-negative individuals should ideally receive Rh-negative blood to avoid developing anti-D antibodies.